Pelthos Therapeutics (PTHS) Liabilities and Shareholders Equity (2022 - 2026)
Pelthos Therapeutics' Liabilities and Shareholders Equity was $137.36 million in Q2 2026, compared with $822,850 a year earlier and down 5.5% from the prior quarter.
Powered by 
Analysis
Pelthos Therapeutics (PTHS) Liabilities and Shareholders Equity (2022 - 2026) Analysis & Trends
At the end of FY2025, Liabilities and Shareholders Equity at Pelthos Therapeutics came in at $130.4 million.
- Liabilities and Shareholders Equity shows a three-year compound annual growth rate of 1232.8% (FY2022 to FY2025).
- In earlier years, Liabilities and Shareholders Equity was $1.37 million in FY2024, $96,391 in FY2023 (+75.0%) and $55,074 in FY2022.
- Quarterly Liabilities and Shareholders Equity has moved between $55,074 (Q4 2022) and $145.38 million (Q1 2026) over five years.
- Per Business Quant data, PTHS's Liabilities and Shareholders Equity in the three quarters before Q2 2026 was $145.38 million (Q1 2026), $130.4 million (Q4 2025) and $126.43 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Pelthos Therapeutics | 79.95 Mn | -8.44 Mn | 11.99 Mn | 137.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 137.36 Mn |
| Mar 31, 2026 | 145.38 Mn |
| Dec 31, 2025 | 130.40 Mn |
| Sep 30, 2025 | 126.43 Mn |
| Jun 30, 2025 | 822,850.00 |
| Mar 31, 2025 | 911,179.00 |
| Dec 31, 2024 | 1.37 Mn |
| Sep 30, 2024 | 2.14 Mn |
| Jun 30, 2024 | 2.60 Mn |
| Mar 31, 2024 | 4.03 Mn |
| Dec 31, 2023 | 96,391.00 |
| Dec 31, 2022 | 55,074.00 |
API Access
Pelthos Therapeutics Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=PTHS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "PTHS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=PTHS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();